Admission and Commencement of Official Quotation
Sydney, Jan 20, 2015 AEST (ABN Newswire) - Phytotech Medical Limited (
ASX:PYL) (Company) was admitted to the Official List of ASX Limited (ASX) on Tuesday, 20 January 2015.
Official quotation of the Company's securities will commence at 2:00 pm Australian Eastern Daylight Savings Time ("AEDST") on Thursday, 22 January 2015. The Company has raised $5,932,410 pursuant to the offer under the prospectus dated 20 November 2014 and supplementary prospectus dated 5 January 2015 issued by the Company (together the "Prospectus") by the issue of 29,662,050 ordinary shares at an issue price of $0.20 per share.
Quoted Securities: 34,462,050 fully paid ordinary shares
ASX Code: PYL
Time: 2pm AEDST
Date: Thursday, 22 January 2015
ASX Trade Abbreviation: PHYTOTECH
ISIN: AU000000PYL8
Home Branch: Perth
Industry Classification: 3520 Pharmaceuticals, Biotechnology & Life Sciences
Registered Office: Suite 9, 330 Churchill Avenue
SUBIACO WA 6008
Ph: (08) 6489 1600
F: (08) 6489 1601
E: info@phytotechmed.com
Company Secretary: Loren Jones
Share Registry: Automic Registry Services
Level 1, 7 Ventnor Avenue
WEST PERTH, WA 6005
Ph: (08) 9324 2099
F: (08) 9321 2337
Balance Date: 30 June
CHESS: Participating. The Company will also operate an issuer sponsored sub-register.
Place of Incorporation: Western Australia
Dividend Policy: See section 2.14 of the Prospectus
Activities: Research, development and commercialisation of medical cannabis delivery systems.
ASX Restricted Securities: 3,000,000 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow for a period of 24 months from the commencement of official quotation
7,200,000 fully paid ordinary shares classified by ASX as restricted securities and to be held in escrow for a period of 12 months from 17 September 2014
2,500,000 options exercisable at $0.20 on the date that is three years after the date of issue to be held in escrow for a period of 24 months from the commencement of official quotation
10,000,000 Class A performance rights as set out at page 93 of the Prospectus to be held in escrow for a period of 24 months from the commencement of official quotation
10,000,000 Class C performance rights as set out at page 93 of the Prospectus to be held in escrow for a period of 24 months from the commencement of official quotation
10,000,000 Class D performance rights as set out at page 93 of the Prospectus to be held in escrow for a period of 24 months from the commencement of official quotation
For further details, please refer to the Company's prospectus dated 20 November 2014 and supplementary prospectus dated 5 January 2015.
About MMJ Group Holdings Ltd
![Phytotech Medical ASX:PYL](https://abnnewswire.net/images/logos/37064en.jpg)
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
Related Companies
Social Media
Share this Article